The Breast Cancer Initiative 2.5 (BCI2.5) represents a new commitment to unite the global breast cancer community behind a common goal to make breast health a global priority and reduce disparities in breast cancer outcomes worldwide. The initiative began as a call for action in 2014 supported by UICC, the American Cancer Society, and Susan G. Komen.
“As the most common cancer among women, breast cancer must be addressed at the global level. Progress made in high income countries has not yet been mirrored in low and middle-income countries. These differences represent a real and tangible opportunity to improve women’s lives."
-Benjamin O. Anderson, Chair and Director of Breast Health Global Initiative, a founding member of BCI2.5
Since that initial pledge, the BCI2.5 has been engaging partners around the world, assessing need, identifying priorities and defining a strategy to meet this goal. Its consensus-based approach empowers regional champions to bring about change with the aid of its analytic, assessment and planning tools, educational materials and implementation science research methodology. The BCI2.5 delivers evidence-based technical expertise and a resource-stratified approach to improving breast health services and care at any resource level. The initiative is inclusive and encourages organizations, institutions and countries to connect and join the effort.
The Organisation of European Cancer (OECI) Institutes is a non-governmental, non-profit legal entity established in 1979 to promote greater cooperation among European Cancer Centres and Institutes.
The OECI is a network of 81 members that collaborate to reduce fragmentation and to provide to all European patients the possibility of receiving the best available cancer care.
UICC and OECI have been historically linked since UICC initiated the organization of the OECI founding meeting in 1977, convening 60 leading personalities in oncology from all over Europe in the Emperor’s Castle in Vienna.
"Since then, the ultimate goal of the OECI is to find new and better treatments, provide more comprehensive care and improve patients’ quality of life by evidence-based medicine with a holistic approach," said Prof. Claudio Lombardo, Director, Organisation of the European Cancer Institutes.
Thanks to its extended network, composed of members offering a wide range of skills, the OECI has the resources to disseminate results to the wider cancer community. The need to grow an active role in supporting the innovation process in personalized medicine, as well as overcoming disparities in patient care, outcomes and access to treatments on a European scale is reflected by the stakeholders’ growing interest in the OECI Accreditation and Designation Programme. This activity focuses on the improvement of the organization and quality levels of cancer centres; it is obtaining international recognition.
Further information can be found on the OECI official website.
UICC has helped to establish a new regional childhood cancer network in Latin America and the Caribbean - the PAHO-led Childhood Cancer Working Group (PAHO-CCWG). The creation of a dedicated regional expert group on childhood cancer was one of the main recommendations of a policy dialogue organized by UICC in Geneva, June 2015 at the Brocher Foundation in Hermance, Switzerland.
The policy dialogue identified a pan-regional need to address health system challenges to improve outcomes for children with cancer and to develop an advocacy agenda for countries at different levels of health system capacity across Latin America and the Caribbean. As an initial activity, a mapping of policy, programmes and services related to childhood cancer in Latin America was started by UICC, Fundación Nuestros Hijos, Childhood Cancer International and the Sick Children’s Hospital in Toronto.
This mapping activity is now being undertaken in collaboration with the new WHO/PAHO regional network, which had its first meeting in Washington DC in early February 2017.
The Global Challenges Research Fund (GCRF) Research Councils UK are supporting research for health in conflict to understand the burden of cancer in conflict populations, beyond current epidemiology estimates, to look into specific clinical outcome and quality metrics, and case fatality rates.
Research will be conducted with national partners to model impacts, map the capacity and capabilities (workforce planning), define priority cancers, modalities and settings (prevention, treatment and care) to develop agreed, costed, and stratified policy recommendations for pathways and models of care.